Complete Filing Data
LightWave Acquisition Corp. reported Net Income Loss of $3.63 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean LightWave Acquisition Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income Loss | $3.6M |
| Operating Income Loss | -$466.1K |
| General And Administrative Expense | $466.1K |
| Nonoperating Income Expense | $4.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Net Income Loss | $2.1M | -$360.7K | -$47.2K |
| Operating Income Loss | -$153.0K | -$87.2K | -$47.2K |
| General And Administrative Expense | $153.0K | $87.2K | $47.2K |
| Nonoperating Income Expense | $2.3M | -$273.5K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stockholders Equity | -$6.7M |
| Temporary Equity Accretion To Redemption Value | $19.2M |
| Retained Earnings Accumulated Deficit | -$6.7M |
| Liabilities Current | $153.3K |
| Liabilities And Stockholders Equity | $221.0M |
| Deferred Offering Costs Paid Through Promissory Note Related Party | $25.0K |
| Deferred Offering Costs Included In Accrued Offering Costs | $75.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $808.8K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $808.8K |
| Assets Current | $916.8K |
| Assets | $221.0M |
| Accounts Payable And Accrued Liabilities Current | $78.3K |
| Temporary Equity Carrying Amount Attributable To Parent | $220.1M |
| Repayments Of Related Party Debt | $144.5K |
| Overpayment On Sponsor Note Payable | $25.0K |
| Liabilities | $7.7M |
| Gain Loss On Sale Of Investments | $4.5M |
| Deferred Underwriting Fee Payable | $7.5M |
| Cash | |
| Assets Held In Trust Noncurrent | $220.1M |
| Accrued Offering Costs | |
| Deferred Compensation Liability Classified Noncurrent | |
| Deferred Underwriting Fee Payable Noncurrent | $7.5M |
| Deferred Costs | |
| Cash And Cash Equivalents At Carrying Value | |
| Accrued Offering Costs Current | $75.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Stockholders Equity | -$6.6M | -$6.4M | -$22.2K |
| Temporary Equity Accretion To Redemption Value | $2.3M | $14.8M | |
| Retained Earnings Accumulated Deficit | -$6.6M | -$6.4M | -$47.2K |
| Liabilities Current | $121.5K | $195.3K | $188.5K |
| Liabilities And Stockholders Equity | $219.1M | $217.0M | $166.3K |
| Deferred Offering Costs Paid Through Promissory Note Related Party | $25.0K | ||
| Deferred Offering Costs Included In Accrued Offering Costs | $126.7K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $14.6K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $902.4K | $1.1M | $14.6K |
| Assets Current | $1.0M | $1.3M | $14.6K |
| Assets | $219.1M | $217.0M | $166.3K |
| Accounts Payable And Accrued Liabilities Current | $31.5K | $97.7K | $36.8K |
| Temporary Equity Carrying Amount Attributable To Parent | $218.0M | $215.7M | |
| Repayments Of Related Party Debt | |||
| Overpayment On Sponsor Note Payable | |||
| Liabilities | $7.7M | $7.7M | |
| Gain Loss On Sale Of Investments | |||
| Deferred Underwriting Fee Payable | |||
| Cash | $14.6K | ||
| Assets Held In Trust Noncurrent | $218.0M | $215.7M | |
| Accrued Offering Costs | $90.1K | $97.6K | $126.7K |
| Deferred Compensation Liability Classified Noncurrent | $7.5M | $7.5M | |
| Deferred Underwriting Fee Payable Noncurrent | |||
| Deferred Costs | $151.7K | ||
| Cash And Cash Equivalents At Carrying Value | $14.6K | ||
| Accrued Offering Costs Current |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Share Based Compensation | $372.0K |
| Proceeds From Issuance Of Common Stock | $25.0K |
| Net Cash Provided By Used In Operating Activities | -$476.9K |
| Net Cash Provided By Used In Financing Activities | $216.9M |
| Proceeds From Related Party Debt | $144.5K |
| Proceeds From Other Equity | $211.3M |
| Proceeds From Issuance Of Private Placement | $6.1M |
| Payments To Acquire Investments | $215.6M |
| Payments Of Stock Issuance Costs | $439.3K |
| Net Cash Provided By Used In Investing Activities | -$215.6M |
| Increase Decrease In Prepaid Expense | $117.8K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $90.1K |
| Increase Decrease In Accrued Liabilities |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 |
|---|---|---|
| Share Based Compensation | $372.0K | |
| Proceeds From Issuance Of Common Stock | $25.0K | |
| Net Cash Provided By Used In Operating Activities | -$10.4K | |
| Net Cash Provided By Used In Financing Activities | $25.0K | |
| Proceeds From Related Party Debt | ||
| Proceeds From Other Equity | ||
| Proceeds From Issuance Of Private Placement | ||
| Payments To Acquire Investments | ||
| Payments Of Stock Issuance Costs | ||
| Net Cash Provided By Used In Investing Activities | ||
| Increase Decrease In Prepaid Expense | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | ||
| Increase Decrease In Accrued Liabilities | $36.8K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Preferred Stock Shares Authorized | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
| Sale Of Stock Number Of Shares Issued In Transaction | 606.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Sale Of Stock Number Of Shares Issued In Transaction | 606.3K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Investment Income Interest | $16.8K |
| Interest Income Other | $4.5M |
| Stock Issued During Period Value New Issues | $25.0K |
| Stock Issued During Period Value Other | $6.1M |
| Repayment Of Promissory Note Related Party | $25.0K |
| Prepaid Expense Current | $10.5K |
| Offering Costs Charged To Additional Paidin Capital | $527.5K |
| Adjustments To Additional Paid In Capital Warrant Issued | $2.5M |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $156.7K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $372.0K |
| Prepaid Insurance Current | $72.5K |
| Prepaid Expense Noncurrent | $34.8K |
| Additional Paid In Capital |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Investment Income Interest | $8.3K | $172.00 | |
| Interest Income Other | $2.3M | $98.3K | |
| Stock Issued During Period Value New Issues | $25.0K | ||
| Stock Issued During Period Value Other | $6.1M | ||
| Repayment Of Promissory Note Related Party | |||
| Prepaid Expense Current | $37.2K | $37.8K | |
| Offering Costs Charged To Additional Paidin Capital | |||
| Adjustments To Additional Paid In Capital Warrant Issued | $2.5M | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $156.7K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $372.0K | ||
| Prepaid Insurance Current | $72.5K | ||
| Prepaid Expense Noncurrent | $53.0K | ||
| Additional Paid In Capital | $24.2K |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.